 LONDON and REDWOOD CITY, Calif., Nov. 23, 2020 GLOBE NEWSWIRE -- Mereo BioPharma Group plc NASDAQ: MREO, AIM: MPH Mereo or the Company, a clinical stage biopharmaceutical company focused on oncology and rare diseases, today announces the appointment of Suba Krishnan, M.D. as Senior Vice President of Clinical Development, effective December 7, 2020. Dr. Krishnan joins Mereo with more than 20 years of experience, encompassing early and late stage immuno-oncology drug development, academia and clinical practice. 